Five-year effectiveness of low-dose-rate brachytherapy: comparisons with nomogram predictions in patients with non-metastatic prostate cancer presenting significant control of intra- and periprostatic disease.
Zimmermann JS, Osieka R, Bruns T, Hollberg H, Wiechmann B, Netzbandt O, Sablotny J, Malade M, Heitz M, Bernhardt F, Tiemann J, Wilkens M, Brüske T, Welker U, Heinemann V, Zimmermann P, de la Maza SF, Pfeiffer D, Tauber PR, Thomas D, Moustakis C.
Zimmermann JS, et al. Among authors: zimmermann p.
J Contemp Brachytherapy. 2018 Aug;10(4):297-305. doi: 10.5114/jcb.2018.77949. Epub 2018 Aug 31.
J Contemp Brachytherapy. 2018.
PMID: 30237813
Free PMC article.